Welcome to our dedicated page for The Beauty Health Company news (Ticker: SKIN), a resource for investors and traders seeking the latest updates and insights on The Beauty Health Company stock.
The Beauty Health Company (NASDAQ: SKIN) generates a steady flow of news at the intersection of medical technology, professional aesthetics, and beauty. As the parent of Hydrafacial, SkinStylus, and Keravive, the company issues regular updates on financial performance, science-backed innovation, provider partnerships, and corporate governance, giving investors and industry followers insight into how its skin health platform is evolving.
On this page, readers can follow earnings announcements and financial results, where BeautyHealth reports net sales, gross margin, adjusted EBITDA, delivery systems sold, and active install base across the Americas, Asia-Pacific, and EMEA. These releases often include management commentary on trends in device sales versus consumables, the performance of the recurring revenue stream, and changes in regional go-to-market strategies.
News coverage also highlights product and innovation updates, such as the launch of boosters like HydraFillic with Pep9 and references to Hydralock HA Booster, as well as insights from the company’s Skintuition Report, which explores consumer trends in modern skin health and aesthetics. Additional stories focus on initiatives like the Hydrafacial Advisory Councils and Ambassador Network, which bring together plastic surgeons, dermatologists, aesthetic practitioners, and estheticians to guide product development, education, and clinical research.
Corporate and governance news includes executive appointments, board changes, and capital structure developments, such as the appointment of a new President and Chief Executive Officer, the addition of a new independent director, and updates related to convertible senior notes and charter amendments. For anyone tracking SKIN, this news feed offers a centralized view of the company’s operational progress, strategic priorities, and role in professional skin and scalp health.
The Beauty Health Company (NASDAQ:SKIN) will report its second quarter 2022 financial results on August 9, 2022, before market open. Following this, an investor conference call is scheduled for 8:30 a.m. Eastern Time. Investors and analysts can join the call via webcast, with a recording available three hours post-call. HydraFacial, the company's flagship brand, operates in over 90 countries with more than 21,000 delivery systems.
The Beauty Health Company (NASDAQ:SKIN) has expanded its partnership with Murad to launch the new Clarifying Booster for HydraFacial, designed for breakout-prone skin. This booster uses powerful ingredients like Salicylic Acid and Glycolic Acid for exfoliation, combined with Ginger Root Complex and Witch Hazel to soothe and purify the skin. This collaboration enhances the HydraFacial experience, offering a scientifically proven formulation that promotes clearer skin. The new booster complements existing Murad offerings and reinforces the brands' commitment to innovative skincare solutions.
The Beauty Health Company (NASDAQ:SKIN) announced the immediate appointment of Marla Beck, founder of Bluemercury, to its Board of Directors. Beck's extensive experience in leading growth-stage companies and her entrepreneurial accolades, including being an Ernst and Young Entrepreneur of the Year National Finalist, position her as a transformative addition to the board. Executive Chairman Brent Saunders expressed confidence in Beck’s ability to provide fresh perspectives and drive the company's growth as it seeks to enhance consumer self-confidence through its HydraFacial brand.
The Beauty Health Company (NASDAQ: SKIN) announced that its CEO Andrew Stanleick and CFO Liyuan Woo will present at multiple investor conferences this spring. Key events include the Cowen & Company 6th Annual Future of the Consumer Conference on May 24, 2022, the William Blair 42nd Annual Growth Stock Conference on June 9, 2022, and the Jefferies Global Consumer Conference from June 20 to 22, 2022. Replays of these presentations will be available on the company’s investor relations website.
The Beauty Health Company (NASDAQ:SKIN) announces its second annual GLOWvolution tour, starting May 20 in Fort Worth, TX. This mobile spa will visit five cities, offering complimentary HydraFacial treatments. Featuring 11 treatment chairs and additional outdoor setups, the tour aims to engage consumers and enhance brand visibility. The tour also allows participants to share their experiences on social media. With a growing footprint of 21,719 HydraFacial Delivery Systems in over 90 countries, the company is focused on democratizing skincare solutions.
The Beauty Health Company (NASDAQ:SKIN) has announced a partnership with JLo Beauty, launching the HydraFacial x JLo Beauty Booster. This innovative treatment, inspired by the 'JLo Glow,' features ingredients like Olive Leaf Extract, Fermented Adaptogens, and Hygroplex HHG to enhance skin radiance and hydration. The Booster will be available in the U.S. starting September 2022, promising customized skincare experiences through HydraFacial's existing treatment solutions. CEO Andrew Stanleick expressed excitement about the collaboration, aiming to elevate skin health for consumers.
Beauty Health Company (NASDAQ:SKIN) reported strong Q1 2022 financial results, with net sales reaching $75.4 million, a 58.6% increase from Q1 2021. Key drivers included the successful launch of the Syndeo delivery system, contributing $41.6 million in sales. Gross profit stood at $51.9 million with a gross margin of 68.9%.
Despite a net income of $32.5 million, the company incurred an adjusted net loss of $8.5 million. Management raised fiscal 2022 guidance for net sales to $330 million–$340 million.
The Beauty Health Company (NASDAQ: SKIN) appointed Amy Juaristi as Head of Corporate Affairs, a new position aimed at enhancing strategic communications. With over two decades in beauty and healthcare, Juaristi previously led corporate affairs at Coty and has experience with brands like Zocdoc and Chobani. CEO Andrew Stanleick expressed enthusiasm about her leadership, highlighting her ability to effectively tell the stories of growth-driven brands. The company aims to strengthen its position in the beauty health category as it expands its global reach.
The Beauty Health Company (NASDAQ:SKIN) will report its first quarter 2022 financial results after market close on May 10, 2022. A conference call will follow at 4:30 p.m. Eastern Time to discuss these results. The company emphasizes its innovative approach in the beauty and aesthetics market with its flagship brand, HydraFacial, used in over 20,000 installations across 90 countries. This non-invasive treatment has democratized skincare, providing millions of consumer experiences annually.
The Beauty Health Company (NASDAQ:SKIN) will hold its 2022 Annual Stockholders’ Meeting on June 28, 2022, at 2:00 p.m. Eastern Time, in a virtual-only format. Stockholders can attend via live audio webcast, with no physical location available. Voting options include electronic, mail, or phone prior to the meeting. The record date for eligible stockholders is April 29, 2022. The proxy statement will be filed in mid-May, detailing how to access the meeting and vote.